Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Plasmids01:28

Plasmids

4.0K
Plasmids are extrachromosomal DNA molecules found in bacteria, archaea, and some eukaryotic microbes like yeast. These small, circular DNA structures typically contain fewer than 30 genes, although some may exist linearly. Plasmids vary in their number within a cell, known as copy number. Single-copy plasmids are present in one copy per cell and multi-copy plasmids are present in multiple copies, reaching over 100 copies per cell.Plasmids usually replicate independently of the chromosomal DNA...
4.0K
Production of Pharmaceuticals01:30

Production of Pharmaceuticals

66
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
66
Upstream Processing01:27

Upstream Processing

81
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
81
Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

357
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
357
Bioplastics01:27

Bioplastics

48
Bioplastics derived from microbial processes present a sustainable alternative to conventional petroleum-based plastics. Among these, polyhydroxyalkanoates (PHAs), particularly polyhydroxybutyrates (PHBs), have emerged as prominent candidates due to their biodegradability and biocompatibility. These polymers are synthesized by a variety of bacteria, such as Cupriavidus necator and Pseudomonas putida, which naturally accumulate PHAs as intracellular carbon and energy reserves, especially under...
48
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

5.1K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of Vibrio natriegens as a fast-growing alternative host for plasmid DNA production.

Microbial cell factories·2026
Same author

Endovascular treatment as first-line therapy in Spetzler-Martin grade III brain arteriovenous malformations: a systematic review and meta-analysis.

Journal of neurosurgical sciences·2026
Same author

Screening of a Combinatorial Library of Triazine-Scaffolded Dipeptide-Mimic Affinity Ligands to Bind Plasmid DNA.

Molecules (Basel, Switzerland)·2025
Same author

Engineering <i>Escherichia coli</i> Biofilms for Curcumin Production.

Molecules (Basel, Switzerland)·2025
Same author

Continuous collection of human mesenchymal-stromal-cell-derived extracellular vesicles from a stirred tank reactor operated under xenogeneic-free conditions for therapeutic applications.

Stem cell research & therapy·2025
Same author

Quantification of ssDNA Scaffold Production by Ion-Pair Reverse Phase Chromatography.

ACS omega·2024
Same journal

Structures of the endophytic microbiota during heart rot development in <i>Abies georgei</i> var. <i>smithii</i>.

Microbiology spectrum·2026
Same journal

High <i>Yersinia</i> prevalence in tonsils of wild boars hunted in Northeast Germany using a novel protocol including long cold enrichment.

Microbiology spectrum·2026
Same journal

Genetic variation, recombinant characteristics, and seroprevalence analysis of echovirus 3 causing severe and mild cases of hand, foot, and mouth disease in Guizhou Province.

Microbiology spectrum·2026
Same journal

Mycelial morphology influenced aerobic DNRA in <i>Streptomyces mediolani</i> EM-B2: short rod-shaped mycelium showed markedly greater efficiency than long filamentous mycelium.

Microbiology spectrum·2026
Same journal

Performance and practicality of 16S nanopore sequencing for routine bacterial identification in clinical samples.

Microbiology spectrum·2026
Same journal

Molecular characterization and correlation with β-lactam resistance of penicillin-binding protein2x, 2b, and 1a of <i>Streptococcus pneumoniae</i> in clinical pneumococcal isolates.

Microbiology spectrum·2026
See all related articles

Related Experiment Video

Updated: Apr 8, 2026

Plasmid Stability Analysis with Open-Source Droplet Microfluidics
07:43

Plasmid Stability Analysis with Open-Source Droplet Microfluidics

Published on: December 27, 2024

1.4K

Plasmid Biopharmaceuticals.

Duarte Miguel F Prazeres1, Gabriel A Monteiro1

  • 1IBB, Institute for Biotechnology and Bioengineering, Centre for Biological and Chemical Engineering, Department of Bioengineering, Instituto Superior Técnico, Universidade de Lisboa, 1049-001 Lisboa, Portugal.

Microbiology Spectrum
|June 25, 2015
PubMed
Summary
This summary is machine-generated.

Plasmids are vital tools in biotechnology and medicine, advancing gene therapy and DNA vaccines. This review covers their progress, applications, delivery methods, safety, and manufacturing for therapeutic use.

More Related Videos

Streamlined Purification of Plasmid DNA From Prokaryotic Cultures
06:53

Streamlined Purification of Plasmid DNA From Prokaryotic Cultures

Published on: January 5, 2011

20.6K
Optimization and Utilization of Agrobacterium-mediated Transient Protein Production in Nicotiana
23:21

Optimization and Utilization of Agrobacterium-mediated Transient Protein Production in Nicotiana

Published on: April 19, 2014

42.6K

Related Experiment Videos

Last Updated: Apr 8, 2026

Plasmid Stability Analysis with Open-Source Droplet Microfluidics
07:43

Plasmid Stability Analysis with Open-Source Droplet Microfluidics

Published on: December 27, 2024

1.4K
Streamlined Purification of Plasmid DNA From Prokaryotic Cultures
06:53

Streamlined Purification of Plasmid DNA From Prokaryotic Cultures

Published on: January 5, 2011

20.6K
Optimization and Utilization of Agrobacterium-mediated Transient Protein Production in Nicotiana
23:21

Optimization and Utilization of Agrobacterium-mediated Transient Protein Production in Nicotiana

Published on: April 19, 2014

42.6K

Area of Science:

  • Molecular Biology
  • Biotechnology
  • Gene Therapy

Background:

  • Plasmids are essential molecular tools in life sciences and biotechnology.
  • They have emerged as key biopharmaceuticals for gene therapy and DNA vaccination over the last two decades.

Purpose of the Study:

  • To provide a concise overview of scientific progress in plasmid biopharmaceuticals.
  • To update researchers on the latest developments in the field.

Main Methods:

  • Review of initial breakthroughs and innovations in plasmid technology.
  • Discussion of molecular characteristics and design of plasmid vectors for gene transfer.
  • Description of in vivo delivery methods (gene gun, electroporation, lipid/polymer complexes, nanoparticles).

Main Results:

  • Plasmids are increasingly used for therapeutic and prophylactic interventions.
  • Key delivery methods and their underlying rationale are detailed.
  • Major safety concerns, including integration and autoimmunity, are addressed.

Conclusions:

  • Plasmids represent a significant advancement in biopharmaceutical development.
  • Understanding their design, delivery, and safety is crucial for future applications.
  • Large-scale manufacturing and approved products highlight their therapeutic potential.